Skip to content

BioSenic (formerly Bone Therapeutics) uploaded a News Release
October 30, 2020

Follow

Bone Therapeutics Provides Third Quarter 2020 Business Update

  • Manufacturing collaboration with Catalent to streamline future ALLOB production
  • Catalent to acquire Bone Therapeutics’ cell therapy manufacturing facility for €12 million
  • Exclusive license agreement with Link Health and Pregene for €55 million total in upfront and milestone payments to develop and commercialize ALLOB in Greater China and adjacent Asian countries
  • Expansion of the product portfolio from orthopedics into inflammatory conditions
About Us | Please read our Privacy Policy, Cookie Policy, Disclaimer and Terms and Conditions. By accessing or using the Service you agree to be bound by these Terms. © 2024 Arrowhed Business and Investment Decisions, LLC.